title: Retinoic acid therapy for promyelocytic leukaemia.
authors.forename: C
authors.initials: C
authors.lastname: Chomienne
authors.forename: P
authors.initials: P
authors.lastname: Ballerini
authors.forename: N
authors.initials: N
authors.lastname: Balitrand
authors.forename: M
authors.initials: M
authors.lastname: Amar
authors.forename: J F
authors.initials: JF
authors.lastname: Bernard
authors.forename: P
authors.initials: P
authors.lastname: Boivin
authors.forename: M T
authors.initials: MT
authors.lastname: Daniel
authors.forename: R
authors.initials: R
authors.lastname: Berger
authors.forename: S
authors.initials: S
authors.lastname: Castaigne
authors.forename: L
authors.initials: L
authors.lastname: Degos
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D014212:Tretinoin; D015474:Isotretinoin